Verition Fund Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-92,701
Closed -$446K – 2389
2025
Q4
$446K Buy
92,701
+9,800
+12% +$47.4K ﹤0.01% 2751
2025
Q3
$419K Buy
82,901
+54,017
+187% +$239K ﹤0.01% 3125
2025
Q2
$116K Buy
+28,884
New +$94K ﹤0.01% 3466
2024
Q3
– Sell
-11,502
Closed -$40K – 3199
2024
Q2
$40K Buy
+11,502
New +$38.4K ﹤0.01% 2811
2023
Q4
– Sell
-19,443
Closed -$50.4K – 2350
2023
Q3
$50.4K Buy
+19,443
New +$68.3K ﹤0.01% 2186

Other funds holding SRTA

Verition Fund Management's SRTA Position: Q1 2026 in Review

Verition Fund Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 92,701 shares — an estimated $446K sold.

Verition Fund Management first reported a position in SRTA in Q3 2023 and held it in 5 quarters. The position peaked at $446K in Q4 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Verition Fund Management reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 92,701 Strata Critical Medical Inc shares in Q1 2026, an estimated $446K.
  • Verition Fund Management first reported a position in Strata Critical Medical Inc in Q3 2023 and held it in 5 quarters.
  • Verition Fund Management's Strata Critical Medical Inc position peaked at $446K in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.